Care pathways & referral

FDA Is Asking the Right AI Question: Who Watches the Model After Approval?

Cardiac rehabilitation is now explicitly personalised in Europe. Reimbursement could decide who gets it

The same weight loss produced different metabolic benefits. Diet quality may matter as much as kilograms lost

Endometrial Cancer Prehab Should Not Be a Luxury Experiment

Myasthenia Care Cannot Wait for Crisis

Dermatophilus Changed Pattern.

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

C. Diff Can Hide in Plain Sight.

Radiopharmaceuticals Just Got a Necessary No
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
